| 📊 Record Q3 performance drives growth momentum: The stock is attracting attention after reporting very strong Q3 2026 results. The company, known for its SmartVest breathing therapy device, increased revenue by 18.4% and beat earnings expectations. Analysts believe the company still has a lot of room to grow because many bronchiectasis patients are still not using this type of treatment. Strong insurance coverage, growing demand, and improving sales have helped make this stock one of the top-rated medical device stocks right now.
See the ratings here >> |